HOME >> MEDICINE >> NEWS
Outpatient procedure shrinks benign breast lumps

ned for surgical removal. On average, the fibroadenomas were reduced in size by 73 percent. No significant complications were noted, and patients were pleased with the cosmetic results.

Affecting 10 percent of American women, most in their late teens and early 20s, fibroadenomas are often considered a leave-alone lesion. However, approximately 1 million are removed annually because of size, continued growth or for cosmetic reasons. African-American women have twice the incidence of fibroadenomas as Caucasian women. The ability to conserve breast tissue is also highly desirable in the treatment of breast cancer, and Dr. Littrup has begun treating breast cancers under protocol.

Dr. Littrup's co-authors are Laurie Freeman-Gibb, M.S., R.N., Michael White, M.D., Kathy Carolin, M.D., Ted Harb, M.D., and Amit Vyas, M.D. (A grant was received from Sanarus, Inc.)


'"/>

Contact: Maureen Morley
mmorley@rsna.org
630-590-7754
Radiological Society of North America
3-Dec-2003


Page: 1 2

Related medicine news :

1. Outpatient lung cancer procedure promising for inoperable disease
2. Outpatient pediatric visits good opportunity to help parents quit smoking
3. Outpatient treatment shrinks liver tumors to acceptable size for laser procedure
4. Outpatient setting very safe for skin cancer surgery
5. Outpatient treatment is as effective as inpatient treatment for PID
6. 9.2 million cosmetic plastic surgery procedures in 2004 - up 5%
7. Half-million cosmetic plastic surgery procedures for Hispanics in 2004 - up 49% from 2000
8. Massive weight loss patients create mass appeal for body contouring procedures
9. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack
10. Single-donor islet transplantation procedure shows promise for patients with type 1 diabetes
11. New surgical procedure could save millions

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... ... (ONS) wanted to create a communications platform that positions them as the go-to ... and ONS reinvented their online publication as an always-on, always-fresh news, views and ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of ... is pleased to announce Westchester resident Lauren C. Enea has joined the firm as ... firm, will concentrate her practice in elder law, Medicaid planning and applications, and Wills, ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, ... their training and leads programs. , In February, 2017, Empower Brokerage introduced their ... Performance Partners is designed to teach how to maximize their sales efforts, as ...
(Date:3/24/2017)... ... 2017 , ... “End Time GPS”: a dauntless and enlightened study of ... GPS” is the creation of published author, Wesley Gerboth, a World War II veteran, ... space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon him ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Adventures of Joey, The Dog ... dog who lives his life to the fullest, as God intended. “The Adventures of ... Holmgren, a mother and grandmother pursuing her passion for writing, especially about truth and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... FinancialBuzz.com News Commentary  ... According to new data published Arcview ... legal cannabis market is projected to continue to grow at ... the current presidential administration. The report created by Arcview,s data ... growth in this industry are the passage and subsequent implementation ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
Breaking Medicine Technology:
Cached News: